FIELD: medicine, pharmaceutics.
SUBSTANCE: claimed is immunogenic composition for application in treatment or prevention of disease, associated with Clostridium difficile, method of obtaining said composition by mixing ingredients included into its composition and method of inducing immune response to C. Difficile, which includes introduction of said composition to individual. Claimed composition includes toxin or anatoxin of Clostridium difficile and one or several pharmaceutically acceptable excipients, which contain a) buffer, selected from the group of citrate and phosphate, in concentration from 10-30, 15-25 or 20 mM and b) sugar or sugar alcohol, selected from the group, consisting of sorbitol, trehalose and sucrose in concentration 4-20%.
EFFECT: excipients, which are components of composition, increase stability and/or reduce aggregation of toxins, which makes it possible to obtain compositions more stable in storage with preservation of their conformational integrity.
41 cl, 16 dwg, 13 tbl
Title | Year | Author | Number |
---|---|---|---|
COMPOSITIONS AND METHODS RELEVANT TO MUTANT TOXIN FROM CLOSTRIDIUM DIFFICILE | 2013 |
|
RU2630671C2 |
COMPOSITIONS RELATED TO CLOSTRIDIUM DIFFICILE MUTANT TOXIN, AND METHODS OF APPLICATION THEREOF | 2012 |
|
RU2592686C2 |
MULTIVALENT COMPOSITION BASED ON PNEUMOCOCCAL POLYSACCHARIDE-PROTEIN CONJUGATES | 2013 |
|
RU2606152C1 |
POLYVALENT COMPOSITION CONTAINING PNEUMOCOCCAL POLYSACCHARIDE-PROTEIN CONJUGATES | 2013 |
|
RU2605834C2 |
MULTIVALENT COMPOSITION OF PNEUMOCOCCAL POLYSACCHARIDE-PROTEIN CONJUGATE | 2013 |
|
RU2613148C2 |
HUMAN ANTIBODIES TO CLOSTRIDIUM DIFFICILE TOXINS | 2013 |
|
RU2628305C2 |
ANTIBODIES FOR TREATMENT OF INFECTION AND DISEASES ASSOCIATED WITH CLOSTRIDIUM DIFFICILE | 2011 |
|
RU2630663C9 |
METHODS AND COMPOSITIONS FOR VACCINATION OF POULTRY | 2007 |
|
RU2561673C2 |
METHOD OF POULTRY IMMUNISATION AGAINST CLOSTRIDIUM BACTERIA INFECTION | 2007 |
|
RU2409385C2 |
METHOD OF TREATING INFECTIOUS DISEASES USING A COMPOSITION COMPRISING A PLASMA DERIVED IMMUNOGLOBULIN M (IGM) | 2016 |
|
RU2731108C2 |
Authors
Dates
2015-05-10—Published
2008-09-15—Filed